JPS63154660A - １，３，４，５−テトラヒドロベンズ〔ｃｄ〕インド−ル誘導体 - Google Patents
１，３，４，５−テトラヒドロベンズ〔ｃｄ〕インド−ル誘導体Info
- Publication number
- JPS63154660A JPS63154660A JP29970786A JP29970786A JPS63154660A JP S63154660 A JPS63154660 A JP S63154660A JP 29970786 A JP29970786 A JP 29970786A JP 29970786 A JP29970786 A JP 29970786A JP S63154660 A JPS63154660 A JP S63154660A
- Authority
- JP
- Japan
- Prior art keywords
- tetrahydrobenz
- formula
- methylene chloride
- compound
- indole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- GESDFCMCXNVUOI-UHFFFAOYSA-N 1,3,4,5-tetrahydrobenzo[cd]indole Chemical class C1=CC(CCC2)=C3C2=CNC3=C1 GESDFCMCXNVUOI-UHFFFAOYSA-N 0.000 title claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 150000002475 indoles Chemical class 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 abstract description 25
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 abstract description 22
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 abstract description 9
- 239000003814 drug Substances 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000000921 elemental analysis Methods 0.000 description 4
- 239000012046 mixed solvent Substances 0.000 description 4
- 229940124597 therapeutic agent Drugs 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- SPWVRYZQLGQKGK-UHFFFAOYSA-N dichloromethane;hexane Chemical compound ClCCl.CCCCCC SPWVRYZQLGQKGK-UHFFFAOYSA-N 0.000 description 3
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229960003133 ergot alkaloid Drugs 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000015554 Dopamine receptor Human genes 0.000 description 2
- 108050004812 Dopamine receptor Proteins 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 208000023105 Huntington disease Diseases 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 206010034010 Parkinsonism Diseases 0.000 description 2
- 102000003946 Prolactin Human genes 0.000 description 2
- 108010057464 Prolactin Proteins 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 229940054051 antipsychotic indole derivative Drugs 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- -1 lithium aluminum hydride Chemical compound 0.000 description 2
- 229940097325 prolactin Drugs 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000005978 brain dysfunction Effects 0.000 description 1
- 238000000262 chemical ionisation mass spectrometry Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 235000011006 sodium potassium tartrate Nutrition 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Indole Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP29970786A JPS63154660A (ja) | 1986-12-16 | 1986-12-16 | １，３，４，５−テトラヒドロベンズ〔ｃｄ〕インド−ル誘導体 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP29970786A JPS63154660A (ja) | 1986-12-16 | 1986-12-16 | １，３，４，５−テトラヒドロベンズ〔ｃｄ〕インド−ル誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63154660A true JPS63154660A (ja) | 1988-06-27 |
| JPH0569825B2 JPH0569825B2 (enrdf_load_stackoverflow) | 1993-10-01 |
Family
ID=17875994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP29970786A Granted JPS63154660A (ja) | 1986-12-16 | 1986-12-16 | １，３，４，５−テトラヒドロベンズ〔ｃｄ〕インド−ル誘導体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS63154660A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0737670A1 (fr) * | 1995-04-14 | 1996-10-16 | Adir Et Compagnie | Amides tricycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent |
-
1986
- 1986-12-16 JP JP29970786A patent/JPS63154660A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0737670A1 (fr) * | 1995-04-14 | 1996-10-16 | Adir Et Compagnie | Amides tricycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0569825B2 (enrdf_load_stackoverflow) | 1993-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4778891A (en) | Certain pyrano (3,4-f)-indolizine derivatives | |
| JPS62149662A (ja) | Ｎ−含有複素環化合物 | |
| CN110746376B (zh) | 苯并异硒唑酮胺类化合物及其制备方法和用途 | |
| SU841589A3 (ru) | Способ получени гексагидро- - КАРбОлиНОВ или иХ СОлЕй | |
| JPH0327534B2 (enrdf_load_stackoverflow) | ||
| JPS6247190B2 (enrdf_load_stackoverflow) | ||
| JPS63154660A (ja) | １，３，４，５−テトラヒドロベンズ〔ｃｄ〕インド−ル誘導体 | |
| EP0114572A1 (de) | Substituierte Imidazo(1,5-a)pyridine | |
| JPH0560478B2 (enrdf_load_stackoverflow) | ||
| JPS6115875B2 (enrdf_load_stackoverflow) | ||
| US3712928A (en) | Phenylcyclohexane derivatives and methods for their manufacture | |
| Gireaud et al. | Synthesis of 6-amino-6-deoxy-D-gulono-1, 6-lactam and L-gulono-1, 6-lactam derived from corresponding 5, 6-O-sulfinyl hexono-1, 4-lactones | |
| JPS63150262A (ja) | １，３，４，５−テトラヒドロベンズ〔ｃｄ〕インド−ル誘導体 | |
| JPH0569824B2 (enrdf_load_stackoverflow) | ||
| JPH0429674B2 (enrdf_load_stackoverflow) | ||
| JPH0314019B2 (enrdf_load_stackoverflow) | ||
| JPS6263564A (ja) | インド−ル誘導体 | |
| JPS5910358B2 (ja) | 新規エルゴリン誘導体 | |
| JPH0692918A (ja) | ２−アミノメチルシクロプロパン−１−カルボン酸類 | |
| JPH08157475A (ja) | １−ヒドロキシインドール誘導体 | |
| JPH0625258A (ja) | チアザテトラシクロウンデカジエン誘導体 | |
| JPH0234345B2 (enrdf_load_stackoverflow) | ||
| JPS6019800A (ja) | ２４，２５−ジヒドロキシコレステロ−ル誘導体２４−位エピマ−の分離方法 | |
| JPH07285966A (ja) | １，２，３，５−テトラヒドロインドリジン誘導体 | |
| JPH0348664A (ja) | フタラジノン誘導体 |